查看文章

Background:

Failed back surgery syndrome (FBSS) is a cause of significant morbidity for up to 40% of patients following spine surgery, and is estimated to cost almost $20 billion. Treatment options for these patients currently include conventional medical management (CMM), repeat operation, or spinal cord stimulation (SCS). Much of the published data regarding cost-effectiveness of SCS comprise smaller scale RCTs rather than large databases capturing practices throughout the US. SCS has been shown to have superior outcomes to CMM or repeat spinal operation in several landmark studies, yet there are few large studies examining its long-term economic impact.

Objectives:

This study compares healthcare utilization for SCS compared to other management in patients with FBSS.

Study Design:

Retrospective.

Setting:

Inpatient and outpatient sample.

Methods:

Patients with a history of FBSS from 2000–2012 were …